Publications by authors named "Daniel J Cushing"

Claim this Profile
C
Comparative bioavailability of a premixed, ready-to-use formulation of intravenous amiodarone with traditional admixture in healthy subjects.
Daniel J Cushing, Michael P Adams, Warren D Cooper, Bushra Agha, Paul F Souney

J Clin Pharmacol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and platelet aggregation inhibitory effects of a novel intravenous formulation of clopidogrel in humans.
Daniel J Cushing, Paul F Souney, Warren D Cooper, Gerald L Mosher, Michael P Adams

Clin Exp Pharmacol Physiol· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reversal of heparin-induced increases in aPTT in the rat by PM102, a novel heparin antagonist.
Daniel J Cushing, Warren D Cooper, Marlene L Cohen, Julie R S McVoy, Michael Sobel

Eur J Pharmacol· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The hypotensive effect of intravenous amiodarone is sustained throughout the maintenance infusion period.
Daniel J Cushing, Warren D Cooper, Michael R Gralinski, Raymond J Lipicky

Clin Exp Pharmacol Physiol· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PM101: intravenous amiodarone formulation changes can improve medication safety.
Paul F Souney, Warren D Cooper, Daniel J Cushing

Expert Opin Drug Saf· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the effects of PM101, a cyclodextrin-based formulation of intravenous amiodarone, on blood pressure in healthy humans.
Daniel J Cushing, Michael P Adams, Warren D Cooper, Bing Zhang, Raymond J Lipicky

Am J Cardiol· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the cardiac electrophysiology and general toxicology of two formulations of intravenous amiodarone in dogs.
Daniel J Cushing, Warren D Cooper, Michael R Gralinski, Raymond J Lipicky, Peter J Kudenchuk

Cardiovasc Toxicol· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PM101: a cyclodextrin-based intravenous formulation of amiodarone devoid of adverse hemodynamic effects.
Daniel J Cushing, Peter R Kowey, Warren D Cooper, Bill W Massey, Michael R Gralinski

Eur J Pharmacol· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioequivalence of 2 intravenous amiodarone formulations in healthy participants.
Daniel J Cushing, Michael P Adams, Warren D Cooper, Peter R Kowey, Raymond J Lipicky

J Clin Pharmacol· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis